{"name":"Algemeen Ziekenhuis Maria Middelares","slug":"algemeen-ziekenhuis-maria-middelares","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Levobupivacaine Hydrochloride 0.25 % Injectable Solution","genericName":"Levobupivacaine Hydrochloride 0.25 % Injectable Solution","slug":"levobupivacaine-hydrochloride-0-25-injectable-solution","indication":"Other","status":"marketed"},{"name":"Plasma-lyte (dynamic group)","genericName":"Plasma-lyte (dynamic group)","slug":"plasma-lyte-dynamic-group","indication":"Fluid resuscitation in hemorrhage and dehydration","status":"marketed"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"Norepinephrine (dynamic group)","genericName":"Norepinephrine (dynamic group)","slug":"norepinephrine-dynamic-group","indication":"Acute hypotension and shock (septic, cardiogenic, hypovolemic)","status":"marketed"},{"name":"Norepinephrine (static group)","genericName":"Norepinephrine (static group)","slug":"norepinephrine-static-group","indication":"Acute hypotension and shock (septic, cardiogenic, hypovolemic)","status":"marketed"}]},{"name":"Hematology","slug":"hematology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"Plasma-lyte (static group)","genericName":"Plasma-lyte (static group)","slug":"plasma-lyte-static-group","indication":"Fluid resuscitation and maintenance in dehydration","status":"marketed"}]}],"pipeline":[{"name":"Levobupivacaine Hydrochloride 0.25 % Injectable Solution","genericName":"Levobupivacaine Hydrochloride 0.25 % Injectable Solution","slug":"levobupivacaine-hydrochloride-0-25-injectable-solution","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Norepinephrine (dynamic group)","genericName":"Norepinephrine (dynamic group)","slug":"norepinephrine-dynamic-group","phase":"marketed","mechanism":"Norepinephrine is a catecholamine that binds to alpha and beta adrenergic receptors to increase heart rate, blood pressure, and cardiac contractility.","indications":["Acute hypotension and shock (septic, cardiogenic, hypovolemic)","Maintenance of blood pressure during anesthesia"],"catalyst":""},{"name":"Norepinephrine (static group)","genericName":"Norepinephrine (static group)","slug":"norepinephrine-static-group","phase":"marketed","mechanism":"Norepinephrine is a catecholamine that binds to alpha and beta adrenergic receptors to increase heart rate, blood pressure, and cardiac contractility.","indications":["Acute hypotension and shock (septic, cardiogenic, hypovolemic)","Maintenance of blood pressure during anesthesia"],"catalyst":""},{"name":"Plasma-lyte (dynamic group)","genericName":"Plasma-lyte (dynamic group)","slug":"plasma-lyte-dynamic-group","phase":"marketed","mechanism":"Plasma-Lyte is a balanced electrolyte solution that replaces fluid and electrolytes lost through dehydration, hemorrhage, or other clinical conditions.","indications":["Fluid resuscitation in hemorrhage and dehydration","Perioperative fluid maintenance","Electrolyte replacement in critically ill patients"],"catalyst":""},{"name":"Plasma-lyte (static group)","genericName":"Plasma-lyte (static group)","slug":"plasma-lyte-static-group","phase":"marketed","mechanism":"Plasma-Lyte is a balanced electrolyte solution that replaces fluid and electrolytes lost through dehydration, hemorrhage, or other medical conditions.","indications":["Fluid resuscitation and maintenance in dehydration","Perioperative fluid management","Hemorrhage and acute blood loss replacement","Electrolyte imbalance correction"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":5,"phaseCounts":{"marketed":5},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}